WO2001028433A1 - Apparatus and method for expanding the thorax - Google Patents
Apparatus and method for expanding the thorax Download PDFInfo
- Publication number
- WO2001028433A1 WO2001028433A1 PCT/US2000/027981 US0027981W WO0128433A1 WO 2001028433 A1 WO2001028433 A1 WO 2001028433A1 US 0027981 W US0027981 W US 0027981W WO 0128433 A1 WO0128433 A1 WO 0128433A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- separator
- thorax
- sternum
- assembly
- expanded condition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/80—Cortical plates, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates
- A61B17/8061—Cortical plates, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates specially adapted for particular bones
- A61B17/8076—Cortical plates, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates specially adapted for particular bones for the ribs or the sternum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/84—Fasteners therefor or fasteners being internal fixation devices
- A61B17/842—Flexible wires, bands or straps
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S606/00—Surgery
- Y10S606/902—Cortical plate specifically adapted for a particular bone
- Y10S606/905—Rib or sternum plate
Definitions
- the present invention is generally directed to an apparatus and method for treating Chronic Obstructive Pulmonary Disease (COPD).
- COPD Chronic Obstructive Pulmonary Disease
- the present invention is more particularly directed to such an apparatus and method which may be implanted in the human body to expand the thorax and provide additional thoracic volume to support respiratory function.
- COPD Chronic Obstructive Pulmonary Disease
- COPD chronic lung disease
- Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled B-agonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, Ipratropium bromide may be indicated. Further, courses of steroids, such as corticosterocds, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pheumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.
- LVRS lung volume reduction surgery
- Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricular filling. While, lung transplantation is also an option, lung transplantation is considered for only those with advanced COPD. Given the limited availability of donor organs, lung transplants are far from being available to all patients.
- the present invention provides a device and method for treating chronic obstructive pulmonary disease by expanding the thorax of a patient to an expanded condition and maintaining the thorax in the expanded condition.
- a separator is implanted within the thorax. The separator expands the thorax to the expanded condition.
- At least one fastener for example stainless steel suture wire, maintains the separator within the thorax and thereby maintains the expanded condition of the thorax.
- the thorax expansion is implemented by an implantable assembly which includes a separator having opposed sidewalls for engaging facing sidewalls of a sternum resulting from surgical sternotomy.
- the separator has a longitudinal dimension with the opposed sidewalls extending along the longitudinal dimension, and a width dimension, transverse to the longitudinal dimension, separating the opposed sidewalls of the separator and the facing sidewalls of the sternum.
- the separator includes a base having a surface extending from each opposed sidewall.
- the surface extending from each opposed sidewall supports the sternum when the facing sidewalls of the sternum are engaged with the opposed sidewalls of the separator.
- the opposed sidewalls of the separator have a transverse dimension approximately equal to the thickness of the sternum at the facing sidewalls.
- the separator is formed of a biocompatible material such as stainless steel or titanium.
- the separator may be formed of a biocompatible material and include a ceramic covering.
- FIG. 1 is a simplified sectional view of a thorax illustrating a healthy respiratory system
- FIG. 2 is a sectional view similar to FIG. 1 but illustrating a respiratory system suffering from COPD;
- FIG. 3 is a front view of a human rib cage which defines the human thorax
- FIG. 4 is a top plan view of the thorax expander embodying the present invention
- FIG. 5 is an end plan view of the thorax expander of FIG. 4;
- FIG. 6 is a side plan view of the thorax expander of FIG. 4;
- FIG. 7 is a front plan view of a human sternum;
- FIG. 8 is a front plan view of the human sternum of FIG. 7 after a surgical sternotomy
- FIG. 9 is a front plan view of the sternum of FIG. 8 in engagement with a thorax expander embodying the present invention.
- FIG. 10 is a cross-sectional view taken along lines 10-10 of FIG. 9;
- FIG. 11 is a front plan view of the sternum of FIG. 7 in maintained engagement with the thorax expander embodying the present invention for maintaining the thorax in an expanded condition; and
- FIG. 12 is a cross-sectional side view of another thorax expander embodying the present invention.
- FIG. 1 it is a sectional view of a healthy respiratory system 20.
- the respiratory system 20 resides within the thorax 22 which occupies a space defined by the chest wall 24 and the diaphragm 26.
- the respiratory system 20 includes the trachea 28, the left mainstem bronchus 30, the right mainstem bronchus 32, and the bronchial branches 34, 36, 38, 40, and 42.
- the respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56, 58, and 60.
- Each bronchial branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof.
- Characteristic of a healthy respiratory system is the arched or inwardly arcuate diaphragm 26.
- the diaphragm 26 straightens to increase the volume of the thorax 22. This causes a negative pressure within the thorax.
- the negative pressure within the thorax in turn causes the lung lobes to fill with air.
- the diaphragm returns to its original arched condition to decrease the volume of the thorax.
- the decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.
- FIG. 2 illustrates a respiratory system suffering from COPD.
- the lung lobes 52, 54, 56, 58, and 60 are enlarged and that the diaphragm 26 is not arched but substantially straight.
- this individual is incapable of breathing normally by moving the diaphragm 28.
- this individual in order to create the negative pressure in the thorax 22 required for breathing, this individual must move the chest wall outwardly to increase the volume of the thorax. This results in inefficient breathing causing these individuals to breathe rapidly with shallow breaths.
- the apex portion 62 and 66 of the upper lung lobes 52 and 56, respectively, are most affected by COPD.
- the apparatus and method of the present invention treats COPD by deriving the benefits of lung volume reduction surgery without the need of performing lung volume reduction surgery.
- the present invention contemplates permanent expansion of the thorax 22. This leaves extra volume within the thorax for the diaphragm to assume its arched state for acting upon the healthy lung tissue. As previously mentioned, this should result in improved pulmonary function due to enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricle filling.
- FIG. 3 illustrates a rib cage 70 of a human.
- the rib cage 70 forms the chest wall 24 (FIG. 1) defining the thorax 22.
- the rib cage includes the sternum 72 which is a plate of bone forming the middle of the anterior wall of the thorax. Extending arcuately from the sternum 72 are the ribs 74.
- the volume that the thorax occupies may be approximated to that of a cylinder. Since the volume of a cylinder is proportional to the square of the cylinder circumference, a 12% increase in a cylinder circumference provides about a 30% increase in the cylinder volume. Hence, approximately a 12% increase in a patient's chest measurement would yield about a 30% increase in thoracic volume.
- a sternotomy is performed on the sternum 72.
- This is a common surgical procedure wherein the sternum is opened in the midline during open chest surgery and is thus well known. It results in exposed facing sternum surfaces. Further, in accordance with the preferred embodiment, the exposed facing sternum surfaces are separated and a filler or separator is disposed inbetween. The sternum is then sutured with suture wire to the separator for maintaining the thorax in an expanded condition.
- the amount of thorax expansion is of course dependent upon the condition and anatomy of each patient. However, as an example, a 5 to 15% increase in thorax diameter would be sufficient to obtain the benefits otherwise achieved with LVRS.
- FIGS. 4, 5, and 6, they provide top, end, and side plan views respectively of a thorax expanding device 80 embodying the present invention.
- the device includes a separator 82 having opposed sidewalls 84 and 86 along its longitudinal dimension 88.
- the device 80 further includes a base 90 having surfaces 92 and 94 extending from opposed sidewalls 84 and 86 respectively.
- the opposed sidewalls 84 and 86 have a transverse dimension approximately equal to the thickness of the sternum at its midline.
- the separator also includes a width dimension 96, transverse to the longitudinal dimension 88, which defines the separation of the sidewalls 84 and 86 and the extent of increase in the thorax circumference.
- the device 80 may be sutured to the sternum with, for example, suture wire, to maintain the sternum in engagement with the device 80 and to thus maintain the expansion of the thorax. To that end, it will be seen in
- FIG. 6 that the bottom surface 98 of the base 90 includes a plurality of grooves 100 which are arranged to maintain the suture wires in fixed and spaced apart relation.
- FIG. 7 it illustrates a front plan view of the sternum 72.
- the sternum 72 has a midline 102.
- the physician cuts the sternum 72 along the midline 102.
- the facing exposed surfaces 104 and 106 of the sternum 72 are separated. Thereafter, the device 80 is implanted in the thorax as may be seen in FIGS. 9 and 10.
- the exposed facing surfaces 104 and 106 of the sternum are brought into engagement with the opposing sidewalls 84 and 86 respectively of the separator 82. Also, the bottom of the sternum is supported by the surfaces 92 and 94 of the base. It may also be noted in FIG. 10 that the transverse dimension of the sidewalls 84 and 86 is approximately equal to the thickness 108 of the sternum at the exposed facing surfaces 104 and 106.
- the sternum 72 is fixed to the device 80.
- the sternum is fastened to the device 80 with suture wires which are disposed in the channels in the bottom of the base 90.
- the suture wires 110 are preferably formed of stainless steel as is well known in the art. Other fasteners which may be used in place of the suture wires 110 and are well known in the art.
- the procedure is complete. As a result, the volume of the thorax will be expanded because the circumference of the thorax will be increased by the width dimension 96 of the separator 82.
- the device 80 is preferably formed of a biocompatible material.
- Materials suitable for the device 80 may be, for example, stainless steel or titanium.
- a device 120 is shown configured similar to the device 80 of FIGS. 4 through 6 but in addition, it has a body of biocompatible material of, for example, stainless steel or titanium or a ceramic coating 124. In all other respects, the device 120 is essentially identical to the device 80 and may be utilized in the same manner.
- the present invention provides an apparatus and method for treating COPD by expanding the thorax.
- the thorax expansion is achieved through the permanent implantation of a separator which separates the sternum following surgical sternotomy.
- the foregoing is achieved without the need for removing lung tissue.
- the thorax will have an increased volume providing room for the diaphragm to assume its arcuate state to assist in normal breathing and to achieve the benefits of lung volume reduction.
Abstract
A device (80) and method for treating pulmonary disease of a patient. A separator (80) comprises opposing sidewalls (84, 86) and facing surfaces (104, 106) for engaging a sternum (72).
Description
APPARATUS AND METHOD FOR EXPANDING THE THORAX
BACKGROUND OF THE INVENTION
The present invention is generally directed to an apparatus and method for treating Chronic Obstructive Pulmonary Disease (COPD). The present invention is more particularly directed to such an apparatus and method which may be implanted in the human body to expand the thorax and provide additional thoracic volume to support respiratory function.
Chronic Obstructive Pulmonary Disease (COPD) has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structural abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia , and smooth muscle hypertrophy in terminal bronchioles.
The incidence, prevalence, and health-related costs of COPD are on the rise. Mortality due to COPD is also on the rise. In 1991 COPD was the fourth leading cause of death in the United States and had increased 33% since 1979. COPD affects the patient's whole life. It has three main symptoms: cough; breathlessness; and wheeze. At first, breathlessness may be noticed when running for a bus, digging in the garden, or walking up hill. Later, it may be noticed when simply walking in the kitchen. Overtime, it may occur with less and less effort until it is present all of the time. COPD is a progressive disease and currently has no cure. Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below.
The prevention of further respiratory damage entails the adoption of a healthy lifestyle. Smoking cessation is believed to be the single most important therapeutic intervention. However, regular exercise and weight control are also important. Patients whose symptoms restrict their daily activities or who otherwise have an
impaired quality of life may require a pulmonary rehabilitation program including ventilatory muscle training and breathing retraining. Long-term oxygen therapy may also become necessary.
Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled B-agonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, Ipratropium bromide may be indicated. Further, courses of steroids, such as corticosterocds, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pheumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.
About 40 years ago, it was first postulated that the tethering force that tends to keep the intrathoracic airways open was lost in emphysema and that by surgically removing the most affected parts of the lungs, the force could be partially restored. Although the surgery was deemed promising, the procedure was abandoned.
The lung volume reduction surgery (LVRS) was later revived. In the early 1990's, hundreds of patients underwent the procedure. However, the procedure has fallen out of favor due to the fact that Medicare stopped remitting for LVRS. Unfortunately, data is relatively scarce and many factors conspire to make what data exists difficult to interpret. The procedure is currently under review in a controlled clinical trial. However, what data does exist tends to indicate that patients benefited from the procedure in terms of an increase in forced expiratory volume, a decrease in total lung capacity, and a significant improvement in lung function, dyspnea, and quality of life. LVRS is a long and tedious procedure, fraught with potential complications.
Infection is always a concern. Further, lung tissue is difficult to suture and seal making leakage a serious potential problem.
Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricular filling.
While, lung transplantation is also an option, lung transplantation is considered for only those with advanced COPD. Given the limited availability of donor organs, lung transplants are far from being available to all patients.
In view of the foregoing, there is a need in the art for a new and improved therapy for COPD. More specifically, there is a need for such a therapy which could be made available to all COPD patients and which provides more permanent results than pharmacotherapy while being less traumatic than LVRS. The present invention is directed to an apparatus and method which provide such an improved therapy for COPD.
SUMMARY OF THE INVENTION The present invention provides a device and method for treating chronic obstructive pulmonary disease by expanding the thorax of a patient to an expanded condition and maintaining the thorax in the expanded condition. In accordance with one aspect of the present invention, a separator is implanted within the thorax. The separator expands the thorax to the expanded condition. At least one fastener, for example stainless steel suture wire, maintains the separator within the thorax and thereby maintains the expanded condition of the thorax.
In accordance with further aspects of the present invention, the thorax expansion is implemented by an implantable assembly which includes a separator having opposed sidewalls for engaging facing sidewalls of a sternum resulting from surgical sternotomy. The separator has a longitudinal dimension with the opposed sidewalls extending along the longitudinal dimension, and a width dimension, transverse to the longitudinal dimension, separating the opposed sidewalls of the separator and the facing sidewalls of the sternum. As a result, the volume of the thorax is increased and maintained in an expanded condition.
In accordance with further aspects of the present invention, the separator includes a base having a surface extending from each opposed sidewall. The surface extending from each opposed sidewall supports the sternum when the facing sidewalls of the sternum are engaged with the opposed sidewalls of the separator. Preferably, the opposed sidewalls of the separator have a transverse
dimension approximately equal to the thickness of the sternum at the facing sidewalls.
The separator is formed of a biocompatible material such as stainless steel or titanium. Alternatively, the separator may be formed of a biocompatible material and include a ceramic covering.
BRIEF DESCRIPTION OF THE DRAWINGS
The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings in the several figures of which like reference numerals identify identical elements, and wherein:
FIG. 1 is a simplified sectional view of a thorax illustrating a healthy respiratory system;
FIG. 2 is a sectional view similar to FIG. 1 but illustrating a respiratory system suffering from COPD;
FIG. 3 is a front view of a human rib cage which defines the human thorax; FIG. 4 is a top plan view of the thorax expander embodying the present invention;
FIG. 5 is an end plan view of the thorax expander of FIG. 4; FIG. 6 is a side plan view of the thorax expander of FIG. 4; FIG. 7 is a front plan view of a human sternum;
FIG. 8 is a front plan view of the human sternum of FIG. 7 after a surgical sternotomy;
FIG. 9 is a front plan view of the sternum of FIG. 8 in engagement with a thorax expander embodying the present invention;
FIG. 10 is a cross-sectional view taken along lines 10-10 of FIG. 9; FIG. 11 is a front plan view of the sternum of FIG. 7 in maintained engagement with the thorax expander embodying the present invention for maintaining the thorax in an expanded condition; and
FIG. 12 is a cross-sectional side view of another thorax expander embodying the present invention.
DETAILED DESCRIPTION Referring now to FIG. 1 , it is a sectional view of a healthy respiratory system 20. The respiratory system 20 resides within the thorax 22 which occupies a space defined by the chest wall 24 and the diaphragm 26.
The respiratory system 20 includes the trachea 28, the left mainstem bronchus 30, the right mainstem bronchus 32, and the bronchial branches 34, 36, 38, 40, and 42. The respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56, 58, and 60. Each bronchial branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof.
Characteristic of a healthy respiratory system is the arched or inwardly arcuate diaphragm 26. As the individual inhales, the diaphragm 26 straightens to increase the volume of the thorax 22. This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.
In contrast to the healthy respiratory system of FIG. 1 , FIG. 2 illustrates a respiratory system suffering from COPD. Here it may be seen that the lung lobes 52, 54, 56, 58, and 60 are enlarged and that the diaphragm 26 is not arched but substantially straight. Hence, this individual is incapable of breathing normally by moving the diaphragm 28. Instead, in order to create the negative pressure in the thorax 22 required for breathing, this individual must move the chest wall outwardly to increase the volume of the thorax. This results in inefficient breathing causing these individuals to breathe rapidly with shallow breaths. The apex portion 62 and 66 of the upper lung lobes 52 and 56, respectively, are most affected by COPD.
The apparatus and method of the present invention treats COPD by deriving the benefits of lung volume reduction surgery without the need of performing lung volume reduction surgery. As will be seen hereinafter, the present invention contemplates permanent expansion of the thorax 22. This leaves extra volume within the thorax for the diaphragm to assume its arched state for acting upon the healthy lung tissue. As previously mentioned, this should result in improved pulmonary function due to enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricle filling. Referring now to FIG. 3, it illustrates a rib cage 70 of a human. The rib cage 70 forms the chest wall 24 (FIG. 1) defining the thorax 22. The rib cage includes the sternum 72 which is a plate of bone forming the middle of the anterior wall of the thorax. Extending arcuately from the sternum 72 are the ribs 74. The volume that the thorax occupies may be approximated to that of a cylinder. Since the volume of a cylinder is proportional to the square of the cylinder circumference, a 12% increase in a cylinder circumference provides about a 30% increase in the cylinder volume. Hence, approximately a 12% increase in a patient's chest measurement would yield about a 30% increase in thoracic volume.
In accordance with a preferred embodiment of the present invention, a sternotomy is performed on the sternum 72. This is a common surgical procedure wherein the sternum is opened in the midline during open chest surgery and is thus well known. It results in exposed facing sternum surfaces. Further, in accordance with the preferred embodiment, the exposed facing sternum surfaces are separated and a filler or separator is disposed inbetween. The sternum is then sutured with suture wire to the separator for maintaining the thorax in an expanded condition. The amount of thorax expansion is of course dependent upon the condition and anatomy of each patient. However, as an example, a 5 to 15% increase in thorax diameter would be sufficient to obtain the benefits otherwise achieved with LVRS.
Referring now to FIGS. 4, 5, and 6, they provide top, end, and side plan views respectively of a thorax expanding device 80 embodying the present invention. The device includes a separator 82 having opposed sidewalls 84 and 86 along its
longitudinal dimension 88. The device 80 further includes a base 90 having surfaces 92 and 94 extending from opposed sidewalls 84 and 86 respectively. As will be seen hereinafter, the opposed sidewalls 84 and 86 have a transverse dimension approximately equal to the thickness of the sternum at its midline. The separator also includes a width dimension 96, transverse to the longitudinal dimension 88, which defines the separation of the sidewalls 84 and 86 and the extent of increase in the thorax circumference.
As will be seen hereinafter, the device 80 may be sutured to the sternum with, for example, suture wire, to maintain the sternum in engagement with the device 80 and to thus maintain the expansion of the thorax. To that end, it will be seen in
FIG. 6 that the bottom surface 98 of the base 90 includes a plurality of grooves 100 which are arranged to maintain the suture wires in fixed and spaced apart relation. Referring now to FIG. 7 it illustrates a front plan view of the sternum 72. As will be seen in FIG. 7, the sternum 72 has a midline 102. During a surgical sternotomy, the physician cuts the sternum 72 along the midline 102. As will be seen in FIG. 8, this results in the sternum 72 having exposed facing surfaces 104 and 106. In accordance with the present invention, following the surgical sternotomy, the facing exposed surfaces 104 and 106 of the sternum 72 are separated. Thereafter, the device 80 is implanted in the thorax as may be seen in FIGS. 9 and 10.
In FIGS. 9 and 10, the exposed facing surfaces 104 and 106 of the sternum are brought into engagement with the opposing sidewalls 84 and 86 respectively of the separator 82. Also, the bottom of the sternum is supported by the surfaces 92 and 94 of the base. It may also be noted in FIG. 10 that the transverse dimension of the sidewalls 84 and 86 is approximately equal to the thickness 108 of the sternum at the exposed facing surfaces 104 and 106.
Once the device 80 is positioned inbetween the sternum halves resulting from the surgical sternotomy, the sternum 72 is fixed to the device 80. In accordance with this embodiment, as may be seen in FIG. 11 , the sternum is fastened to the device 80 with suture wires which are disposed in the channels in the bottom of the base 90. The suture wires 110 and are preferably formed of stainless steel as is
well known in the art. Other fasteners which may be used in place of the suture wires 110 and are well known in the art.
Once the suture wires 110 are fixedly holding the sternum to the device 80, the procedure is complete. As a result, the volume of the thorax will be expanded because the circumference of the thorax will be increased by the width dimension 96 of the separator 82.
The device 80 is preferably formed of a biocompatible material. Materials suitable for the device 80 may be, for example, stainless steel or titanium. In addition, as illustrated in FIG. 12, a device 120 is shown configured similar to the device 80 of FIGS. 4 through 6 but in addition, it has a body of biocompatible material of, for example, stainless steel or titanium or a ceramic coating 124. In all other respects, the device 120 is essentially identical to the device 80 and may be utilized in the same manner.
As can thus be seen from the foregoing, the present invention provides an apparatus and method for treating COPD by expanding the thorax. The thorax expansion is achieved through the permanent implantation of a separator which separates the sternum following surgical sternotomy. The foregoing is achieved without the need for removing lung tissue. Following the treatment, the thorax will have an increased volume providing room for the diaphragm to assume its arcuate state to assist in normal breathing and to achieve the benefits of lung volume reduction.
While particular embodiments of the present invention have been shown and described, modifications may be made. It is therefore intended in the appended claims to cover all such changes and modifications which fall which fall within the true spirit and scope of the invention.
Claims
1. A device for treating pulmonary disease comprising: means for expanding the thorax of a patient to an expanded condition; and means for maintaining the thorax in the expanded condition.
2. A device for treating pulmonary disease comprising: a separator implantable within a thorax that expands the thorax to an expanded condition; and at least one fastener that maintains the separator within the thorax and thereby maintains the expanded condition of the thorax.
3. The device of claim 2 wherein the separator is implantable within the sternum of the thorax.
4. The device of claim 2 wherein the at least one fastener is a suture wire.
5. An implantable assembly for maintaining a thorax in an expanded condition following surgical sternotomy, the assembly including a separator having opposed sidewalls for engaging facing exposed surfaces of a sternum resulting from the surgical sternotomy, the separator having a longitudinal dimension with the opposed sidewalls extending along the longitudinal dimension, and a width dimension, transverse to the longitudinal dimension, separating the opposed sidewalls of the separator and the facing surfaces of the sternum for increasing the volume of and maintaining the thorax in an expanded condition.
6. The assembly of claim 5 wherein the separator further includes a base having a surface extending from each opposed sidewall for supporting the sternum when the facing surfaces of the sternum are engaged with the opposed sidewalls of the separator.
7. The assembly of claim 6 wherein the opposed sidewalls have a dimension transverse to the surfaces of the base approximately equal to the thickness of the sternum at the facing surfaces.
8. The assembly of claim 5 wherein the separator is formed of a biocompatible material.
9. The assembly of claim 8 wherein the separator is covered with ceramic.
10. The assembly of claim 5 wherein the separator is formed of steel.
11. The assembly of claim 5 wherein the separator is formed of titanium.
12. The assembly of claim 5 further including means for maintaining the facing surfaces of the sternum in engagement with the opposed sidewalls of the separator.
13. The assembly of claim 12 wherein the means for maintaining is suture wire.
14. The assembly of claim 13 wherein the suture wire is formed of stainless steel.
15. The assembly of claim 6 further including suture wires for maintaining the facing surfaces of the sternum in engagement with the opposed sidewalls of the separator.
16. The assembly of claim 15 wherein the base includes a bottom surface including a plurality of grooves for maintaining the suture wires in spaced apart relation.
17. A method of treating a patient having pulmonary disease, the method including the steps of: expanding the thorax of the patient to an expanded condition; and maintaining the thorax in the expanded condition.
18. A method of treating a patient having pulmonary disease, the method including the steps of: implanting a separator within the thorax of the patient to expand the thorax to an expanded condition; and fastening the separator within the thorax to maintain the expanded condition of the thorax.
19. The method of claim 18 wherein the implanting step includes implanting the separator within the sternum of the thorax.
20. The method of claim 18 wherein the fastening step includes fastening the separator within the thorax with suture wire.
21. A method of expanding a thorax and maintaining the thorax in an expanded condition, the method including the steps of: performing a surgical sternotomy on the sternum of the thorax to form exposed facing sternum surfaces along the midline of the sternum; separating the sternum sidewalls; providing a separator having a longitudinal dimension, opposing sidewalls extending along the longitudinal dimension, and a width dimension transverse to the longitudinal dimension; positioning the separator between the exposed sternum surfaces; engaging the exposed surfaces of the sternum with the opposing sidewalls of the separator; and fixing the sternum to the separator for maintaining the facing surfaces of the sternum in engagement with the opposing sidewalls of the separator.
22. The method of claim 21 wherein the fixing step includes suturing the sternum to the separator with suture wire.
23. The method of claim 21 wherein the separator includes a base extending from the opposing sidewalls and wherein the positioning step includes resting the sternum on the base when engaging the exposed facing sternum surfaces with the separator opposing sidewalls.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU80067/00A AU8006700A (en) | 1999-10-20 | 2000-10-10 | Apparatus and method for expanding the thorax |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/422,021 | 1999-10-20 | ||
US09/422,021 US6402754B1 (en) | 1999-10-20 | 1999-10-20 | Apparatus for expanding the thorax |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001028433A1 true WO2001028433A1 (en) | 2001-04-26 |
Family
ID=23673064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/027981 WO2001028433A1 (en) | 1999-10-20 | 2000-10-10 | Apparatus and method for expanding the thorax |
Country Status (3)
Country | Link |
---|---|
US (2) | US6402754B1 (en) |
AU (1) | AU8006700A (en) |
WO (1) | WO2001028433A1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7896887B2 (en) | 2001-10-25 | 2011-03-01 | Spiration, Inc. | Apparatus and method for deployment of a bronchial obstruction device |
US8251067B2 (en) | 2001-03-02 | 2012-08-28 | Pulmonx Corporation | Bronchial flow control devices with membrane seal |
US8474460B2 (en) | 2000-03-04 | 2013-07-02 | Pulmonx Corporation | Implanted bronchial isolation devices and methods |
US8926647B2 (en) | 2002-03-20 | 2015-01-06 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US8932316B2 (en) | 2011-05-13 | 2015-01-13 | Broncus Medical Inc. | Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall |
US8956319B2 (en) | 2002-05-17 | 2015-02-17 | Spiration, Inc. | One-way valve devices for anchored implantation in a lung |
US8974527B2 (en) | 2003-08-08 | 2015-03-10 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US8974484B2 (en) | 2001-09-11 | 2015-03-10 | Spiration, Inc. | Removable lung reduction devices, systems, and methods |
US9198669B2 (en) | 2006-03-31 | 2015-12-01 | Spiration, Inc. | Articulable anchor |
US9326873B2 (en) | 2007-10-12 | 2016-05-03 | Spiration, Inc. | Valve loader method, system, and apparatus |
US9345532B2 (en) | 2011-05-13 | 2016-05-24 | Broncus Medical Inc. | Methods and devices for ablation of tissue |
US9533128B2 (en) | 2003-07-18 | 2017-01-03 | Broncus Medical Inc. | Devices for maintaining patency of surgically created channels in tissue |
US9913969B2 (en) | 2006-10-05 | 2018-03-13 | Broncus Medical Inc. | Devices for delivering substances through an extra-anatomic opening created in an airway |
US10272260B2 (en) | 2011-11-23 | 2019-04-30 | Broncus Medical Inc. | Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5954766A (en) * | 1997-09-16 | 1999-09-21 | Zadno-Azizi; Gholam-Reza | Body fluid flow control device |
US6997189B2 (en) * | 1998-06-05 | 2006-02-14 | Broncus Technologies, Inc. | Method for lung volume reduction |
US6679264B1 (en) | 2000-03-04 | 2004-01-20 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
US20030070683A1 (en) * | 2000-03-04 | 2003-04-17 | Deem Mark E. | Methods and devices for use in performing pulmonary procedures |
US20060020347A1 (en) * | 2004-03-08 | 2006-01-26 | Michael Barrett | Implanted bronchial isolation devices and methods |
US20020112729A1 (en) * | 2001-02-21 | 2002-08-22 | Spiration, Inc. | Intra-bronchial obstructing device that controls biological interaction with the patient |
US20040074491A1 (en) * | 2001-03-02 | 2004-04-22 | Michael Hendricksen | Delivery methods and devices for implantable bronchial isolation devices |
US7798147B2 (en) * | 2001-03-02 | 2010-09-21 | Pulmonx Corporation | Bronchial flow control devices with membrane seal |
US7011094B2 (en) * | 2001-03-02 | 2006-03-14 | Emphasys Medical, Inc. | Bronchial flow control devices and methods of use |
AU2002347900B8 (en) * | 2001-10-11 | 2006-01-12 | Emphasys Medical, Inc. | Bronchial flow control devices and methods of use |
US6929637B2 (en) | 2002-02-21 | 2005-08-16 | Spiration, Inc. | Device and method for intra-bronchial provision of a therapeutic agent |
US20030154988A1 (en) * | 2002-02-21 | 2003-08-21 | Spiration, Inc. | Intra-bronchial device that provides a medicant intra-bronchially to the patient |
US20060235432A1 (en) * | 2002-02-21 | 2006-10-19 | Devore Lauri J | Intra-bronchial obstructing device that controls biological interaction with the patient |
WO2003075796A2 (en) * | 2002-03-08 | 2003-09-18 | Emphasys Medical, Inc. | Methods and devices for inducing collapse in lung regions fed by collateral pathways |
US20030195385A1 (en) * | 2002-04-16 | 2003-10-16 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
EP1507491A1 (en) * | 2002-05-28 | 2005-02-23 | Emphasys Medical, Inc. | Implantable bronchial isolation devices and lung treatment methods |
US20040059263A1 (en) * | 2002-09-24 | 2004-03-25 | Spiration, Inc. | Device and method for measuring the diameter of an air passageway |
WO2004049974A2 (en) | 2002-11-27 | 2004-06-17 | Emphasys Medical, Inc. | Delivery method and device for implantable bronchial isolation devices |
US7814912B2 (en) * | 2002-11-27 | 2010-10-19 | Pulmonx Corporation | Delivery methods and devices for implantable bronchial isolation devices |
US7100616B2 (en) | 2003-04-08 | 2006-09-05 | Spiration, Inc. | Bronchoscopic lung volume reduction method |
US7811274B2 (en) * | 2003-05-07 | 2010-10-12 | Portaero, Inc. | Method for treating chronic obstructive pulmonary disease |
US7426929B2 (en) | 2003-05-20 | 2008-09-23 | Portaero, Inc. | Intra/extra-thoracic collateral ventilation bypass system and method |
US7533667B2 (en) | 2003-05-29 | 2009-05-19 | Portaero, Inc. | Methods and devices to assist pulmonary decompression |
US7200559B2 (en) * | 2003-05-29 | 2007-04-03 | Microsoft Corporation | Semantic object synchronous understanding implemented with speech application language tags |
US7252086B2 (en) | 2003-06-03 | 2007-08-07 | Cordis Corporation | Lung reduction system |
US7377278B2 (en) | 2003-06-05 | 2008-05-27 | Portaero, Inc. | Intra-thoracic collateral ventilation bypass system and method |
US7682332B2 (en) | 2003-07-15 | 2010-03-23 | Portaero, Inc. | Methods to accelerate wound healing in thoracic anastomosis applications |
US20050103340A1 (en) * | 2003-08-20 | 2005-05-19 | Wondka Anthony D. | Methods, systems & devices for endobronchial ventilation and drug delivery |
US20050178389A1 (en) * | 2004-01-27 | 2005-08-18 | Shaw David P. | Disease indications for selective endobronchial lung region isolation |
US8206684B2 (en) * | 2004-02-27 | 2012-06-26 | Pulmonx Corporation | Methods and devices for blocking flow through collateral pathways in the lung |
US7670282B2 (en) | 2004-06-14 | 2010-03-02 | Pneumrx, Inc. | Lung access device |
WO2006009688A2 (en) | 2004-06-16 | 2006-01-26 | Pneumrx, Inc. | Intra-bronchial lung volume reduction system |
EP1781182B1 (en) | 2004-07-08 | 2019-11-13 | PneumRx, Inc. | Pleural effusion treatment device |
US7766891B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Lung device with sealing features |
US20060030863A1 (en) * | 2004-07-21 | 2006-02-09 | Fields Antony J | Implanted bronchial isolation device delivery devices and methods |
US20060079897A1 (en) * | 2004-09-29 | 2006-04-13 | Harrison Michael R | Apparatus and methods for magnetic alteration of anatomical features |
US8439915B2 (en) * | 2004-09-29 | 2013-05-14 | The Regents Of The University Of California | Apparatus and methods for magnetic alteration of anatomical features |
US8043290B2 (en) * | 2004-09-29 | 2011-10-25 | The Regents Of The University Of California, San Francisco | Apparatus and methods for magnetic alteration of deformities |
US8142454B2 (en) * | 2004-09-29 | 2012-03-27 | The Regents Of The University Of California, San Francisco | Apparatus and method for magnetic alteration of anatomical features |
US20060271107A1 (en) * | 2004-09-29 | 2006-11-30 | Harrison Michael R | Apparatus and methods for magnetic alteration of anatomical features |
US7398782B2 (en) | 2004-11-19 | 2008-07-15 | Portaero, Inc. | Method for pulmonary drug delivery |
US8220460B2 (en) | 2004-11-19 | 2012-07-17 | Portaero, Inc. | Evacuation device and method for creating a localized pleurodesis |
US9211181B2 (en) | 2004-11-19 | 2015-12-15 | Pulmonx Corporation | Implant loading device and system |
US7771472B2 (en) | 2004-11-19 | 2010-08-10 | Pulmonx Corporation | Bronchial flow control devices and methods of use |
JP4874259B2 (en) | 2004-11-23 | 2012-02-15 | ヌームアールエックス・インコーポレーテッド | Steerable device for accessing the target site |
US7824366B2 (en) | 2004-12-10 | 2010-11-02 | Portaero, Inc. | Collateral ventilation device with chest tube/evacuation features and method |
US8876791B2 (en) | 2005-02-25 | 2014-11-04 | Pulmonx Corporation | Collateral pathway treatment using agent entrained by aspiration flow current |
US8016887B1 (en) * | 2005-03-24 | 2011-09-13 | Cardinal Spine, Llc | Spinal implant with overlay |
US20060241641A1 (en) * | 2005-04-22 | 2006-10-26 | Sdgi Holdings, Inc. | Methods and instrumentation for distraction and insertion of implants in a spinal disc space |
US8104474B2 (en) | 2005-08-23 | 2012-01-31 | Portaero, Inc. | Collateral ventilation bypass system with retention features |
US7406963B2 (en) | 2006-01-17 | 2008-08-05 | Portaero, Inc. | Variable resistance pulmonary ventilation bypass valve and method |
US8157837B2 (en) | 2006-03-13 | 2012-04-17 | Pneumrx, Inc. | Minimally invasive lung volume reduction device and method |
US8888800B2 (en) | 2006-03-13 | 2014-11-18 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US9402633B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Torque alleviating intra-airway lung volume reduction compressive implant structures |
US7829986B2 (en) * | 2006-04-01 | 2010-11-09 | Stats Chippac Ltd. | Integrated circuit package system with net spacer |
US7931641B2 (en) * | 2007-05-11 | 2011-04-26 | Portaero, Inc. | Visceral pleura ring connector |
US8163034B2 (en) | 2007-05-11 | 2012-04-24 | Portaero, Inc. | Methods and devices to create a chemically and/or mechanically localized pleurodesis |
US20080287878A1 (en) * | 2007-05-15 | 2008-11-20 | Portaero, Inc. | Pulmonary visceral pleura anastomosis reinforcement |
US8062315B2 (en) | 2007-05-17 | 2011-11-22 | Portaero, Inc. | Variable parietal/visceral pleural coupling |
US8043301B2 (en) | 2007-10-12 | 2011-10-25 | Spiration, Inc. | Valve loader method, system, and apparatus |
WO2009105432A2 (en) | 2008-02-19 | 2009-08-27 | Portaero, Inc. | Devices and methods for delivery of a therapeutic agent through a pneumostoma |
US8475389B2 (en) | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Methods and devices for assessment of pneumostoma function |
US8336540B2 (en) | 2008-02-19 | 2012-12-25 | Portaero, Inc. | Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease |
US9173669B2 (en) | 2008-09-12 | 2015-11-03 | Pneumrx, Inc. | Enhanced efficacy lung volume reduction devices, methods, and systems |
US20100114103A1 (en) * | 2008-11-06 | 2010-05-06 | The Regents Of The University Of California | Apparatus and methods for alteration of anatomical features |
US8347881B2 (en) | 2009-01-08 | 2013-01-08 | Portaero, Inc. | Pneumostoma management device with integrated patency sensor and method |
US8518053B2 (en) | 2009-02-11 | 2013-08-27 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
CN104622599B (en) | 2009-05-18 | 2017-04-12 | 纽姆克斯股份有限公司 | Cross-sectional modification during deployment of an elongate lung volume reduction device |
US8795241B2 (en) | 2011-05-13 | 2014-08-05 | Spiration, Inc. | Deployment catheter |
JP2017525527A (en) * | 2014-07-23 | 2017-09-07 | ラシッド マズハル モハンマド エム.ハクRashid Mazhar Mohammad M.Haque | Space shaping device for sternotomy surgery |
CN106687051A (en) | 2014-07-23 | 2017-05-17 | 拉希德·马兹哈尔·穆罕默德·M·哈克 | Sternotomy spacing device |
US10390838B1 (en) | 2014-08-20 | 2019-08-27 | Pneumrx, Inc. | Tuned strength chronic obstructive pulmonary disease treatment |
US9827026B1 (en) * | 2014-09-30 | 2017-11-28 | Allscripts Software, Llc | Nuss procedure aid |
EP3644865A4 (en) | 2017-06-30 | 2021-03-03 | The Regents of The University of California | Magnetic devices, systems, and methods |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4896668A (en) * | 1986-04-10 | 1990-01-30 | Peters | Plate set for osteal fixation, equipped with suture strands |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4583541A (en) * | 1984-05-07 | 1986-04-22 | Barry Joseph P | Sternal stabilization device |
US4852552A (en) * | 1987-09-03 | 1989-08-01 | Pilling Co. | Sternal retractor |
US5356412A (en) * | 1992-10-09 | 1994-10-18 | United States Surgical Corporation | Sternum buckle with rotational engagement and method of closure |
US5415658A (en) * | 1993-12-14 | 1995-05-16 | Pioneer Laboratories, Inc. | Surgical cable loop connector |
US5772583A (en) * | 1994-01-21 | 1998-06-30 | Wright; John T. M. | Sternal retractor with attachments for mitral & tricuspid valve repair |
US6146384A (en) * | 1995-10-13 | 2000-11-14 | Sdgi Holdings, Inc. | Orthopedic fixation device and method of implantation |
US5895387A (en) * | 1996-10-09 | 1999-04-20 | Romulo Guerrero | Method of craniofacial bone distraction |
US6024759A (en) * | 1998-05-08 | 2000-02-15 | Walter Lorenz Surgical, Inc. | Method and apparatus for performing pectus excavatum repair |
-
1999
- 1999-10-20 US US09/422,021 patent/US6402754B1/en not_active Expired - Lifetime
-
2000
- 2000-10-10 AU AU80067/00A patent/AU8006700A/en not_active Abandoned
- 2000-10-10 WO PCT/US2000/027981 patent/WO2001028433A1/en active Application Filing
-
2001
- 2001-07-24 US US09/912,613 patent/US6569166B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4896668A (en) * | 1986-04-10 | 1990-01-30 | Peters | Plate set for osteal fixation, equipped with suture strands |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8474460B2 (en) | 2000-03-04 | 2013-07-02 | Pulmonx Corporation | Implanted bronchial isolation devices and methods |
US8251067B2 (en) | 2001-03-02 | 2012-08-28 | Pulmonx Corporation | Bronchial flow control devices with membrane seal |
US8974484B2 (en) | 2001-09-11 | 2015-03-10 | Spiration, Inc. | Removable lung reduction devices, systems, and methods |
US8986336B2 (en) | 2001-10-25 | 2015-03-24 | Spiration, Inc. | Apparatus and method for deployment of a bronchial obstruction device |
US7896887B2 (en) | 2001-10-25 | 2011-03-01 | Spiration, Inc. | Apparatus and method for deployment of a bronchial obstruction device |
US8926647B2 (en) | 2002-03-20 | 2015-01-06 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US8956319B2 (en) | 2002-05-17 | 2015-02-17 | Spiration, Inc. | One-way valve devices for anchored implantation in a lung |
US9533128B2 (en) | 2003-07-18 | 2017-01-03 | Broncus Medical Inc. | Devices for maintaining patency of surgically created channels in tissue |
US9622752B2 (en) | 2003-08-08 | 2017-04-18 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US8974527B2 (en) | 2003-08-08 | 2015-03-10 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
US11357960B2 (en) | 2004-07-19 | 2022-06-14 | Broncus Medical Inc. | Devices for delivering substances through an extra-anatomic opening created in an airway |
US10369339B2 (en) | 2004-07-19 | 2019-08-06 | Broncus Medical Inc. | Devices for delivering substances through an extra-anatomic opening created in an airway |
US9198669B2 (en) | 2006-03-31 | 2015-12-01 | Spiration, Inc. | Articulable anchor |
US9913969B2 (en) | 2006-10-05 | 2018-03-13 | Broncus Medical Inc. | Devices for delivering substances through an extra-anatomic opening created in an airway |
US9326873B2 (en) | 2007-10-12 | 2016-05-03 | Spiration, Inc. | Valve loader method, system, and apparatus |
US8932316B2 (en) | 2011-05-13 | 2015-01-13 | Broncus Medical Inc. | Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall |
US9486229B2 (en) | 2011-05-13 | 2016-11-08 | Broncus Medical Inc. | Methods and devices for excision of tissue |
US9993306B2 (en) | 2011-05-13 | 2018-06-12 | Broncus Medical Inc. | Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall |
US9421070B2 (en) | 2011-05-13 | 2016-08-23 | Broncus Medical Inc. | Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall |
US10631938B2 (en) | 2011-05-13 | 2020-04-28 | Broncus Medical Inc. | Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall |
US9345532B2 (en) | 2011-05-13 | 2016-05-24 | Broncus Medical Inc. | Methods and devices for ablation of tissue |
US10272260B2 (en) | 2011-11-23 | 2019-04-30 | Broncus Medical Inc. | Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall |
Also Published As
Publication number | Publication date |
---|---|
US20010041906A1 (en) | 2001-11-15 |
US6569166B2 (en) | 2003-05-27 |
AU8006700A (en) | 2001-04-30 |
US6402754B1 (en) | 2002-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6569166B2 (en) | Method for expanding the thorax | |
US6416554B1 (en) | Lung reduction apparatus and method | |
US6258100B1 (en) | Method of reducing lung size | |
EP1078601B1 (en) | Kit for lung volume reduction | |
US6592594B2 (en) | Bronchial obstruction device deployment system and method | |
AU2003225044B2 (en) | Removable anchored lung volume reduction devices and methods | |
US7757692B2 (en) | Removable lung reduction devices, systems, and methods | |
AU2002362449B2 (en) | Constriction device including reinforced suture holes | |
US20020112729A1 (en) | Intra-bronchial obstructing device that controls biological interaction with the patient | |
US20030212412A1 (en) | Intra-bronchial obstructing device that permits mucus transport | |
AU2002349977A1 (en) | Bronchial obstruction device deployment system and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |